Kim J Robertson
1PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Aug 04, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer.Mirat Shah, Christy L Osgood, Anup K Amatya
Pageof 1
Frequent Collaborators
1 joint publications
Mirat Shah
1 joint publications
Christy L Osgood
1 joint publications
Anup K Amatya
1 joint publications
Mallorie H Fiero
1 joint publications
William F Pierce
1 joint publications
Abhilasha Nair
1 joint publications
Bronwyn D Mixter
1 joint publications
Shenghui Tang
1 joint publications
Richard Pazdur
1 joint publications
Julia A Beaver
